Loading...

We're making the next batch
Ships in ~7 days or less
These products are for laboratory research only and not intended for medical use. They must be handled by qualified professionals in controlled laboratory environments. This compound has not been evaluated by the FDA and is not approved for human or veterinary use.
Third-party tested for purity, identity, and quantity.
GLP-3 is supplied as a lyophilized (freeze-dried) white to off-white powder. Purity is ≥98% as determined by HPLC analysis, and the product is accompanied by a certificate of analysis (CoA) confirming identity by mass spectrometry. This material is intended exclusively for laboratory research use.
Published preclinical research on peptides of this class has employed standard in vitro systems, including receptor-expressing cell lines and general laboratory assay models. This material is supplied for in vitro laboratory research use only and is not intended for human or animal use.
No. GLP-3 supplied by this vendor is strictly for in vitro laboratory and preclinical research use only. It is not approved by the FDA or any regulatory authority for human administration, therapeutic application, or diagnostic use. It must not be used in humans or animals outside of formally approved research protocols.
This material is characterized in standard in vitro laboratory systems (for example, receptor-expressing or reporter cell lines and biochemical assays). It is supplied for in vitro laboratory research use only and is not intended for human or animal use.
Quality controlled from start to finish. No outsourcing.
GLP-3 is a 39-amino-acid triple receptor agonist peptide with binding activity at the GIP, GLP-1, and glucagon receptors. It is used as a research reagent for in vitro investigation of multi-receptor incretin signaling and receptor pharmacology. Supplied as a lyophilized powder for laboratory research use only; not for human or animal use.